Diseases, Conditions, Syndromes

Kala-azar treatment failing in Nepal

In a recent study, scientists have concluded that the cure rates of Miltefosine, the only oral drug for visceral leishmaniasis available, have significantly decreased. Miltefosine was introduced in the Indian subcontinent ...

Diseases, Conditions, Syndromes

C. diff scientists reveal potential target to fight infections

Researchers at Virginia Bioinformatics Institute at Virginia Tech have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.

Diseases, Conditions, Syndromes

Researcher's surprising finding could lead to glanders vaccine

(Medical Xpress)—Apichai Tuanyok dedicated several years to working on a bacterial pathogen in Canada, but his breakthrough occurred in Flagstaff with an unexpected finding on a routine lab report.

Diseases, Conditions, Syndromes

Researchers show long-term consequences of chronic virus infection

The cytomegalovirus (CMV) is a member of the herpesvirus family. Although most people carry CMV for life, it hardly ever makes them sick. Researchers from the Helmholtz Centre for Infection Research and from the USA have ...

Diseases, Conditions, Syndromes

Improving human immunity to malaria

The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells.

page 8 from 10